Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
MLSS 
Milestone Scientific (MLSS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: MLSS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $1.62
1 Year Target Price $1.62
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -48.8% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 34.97M USD | Price to earnings Ratio - | 1Y Target Price 1.62 |
Price to earnings Ratio - | 1Y Target Price 1.62 | ||
Volume (30-day avg) 2 | Beta 0.88 | 52 Weeks Range 0.38 - 1.39 | Updated Date 10/17/2025 |
52 Weeks Range 0.38 - 1.39 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.08 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -76.78% | Operating Margin (TTM) -63.9% |
Management Effectiveness
Return on Assets (TTM) -43.59% | Return on Equity (TTM) -123.51% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 35179564 | Price to Sales(TTM) 3.85 |
Enterprise Value 35179564 | Price to Sales(TTM) 3.85 | ||
Enterprise Value to Revenue 3.87 | Enterprise Value to EBITDA -6.86 | Shares Outstanding 78559147 | Shares Floating 62212560 |
Shares Outstanding 78559147 | Shares Floating 62212560 | ||
Percent Insiders 21.34 | Percent Institutions 5.89 |
Upturn AI SWOT
Milestone Scientific
Company Overview
History and Background
Milestone Scientific Inc. was founded in 1989. Initially focused on computer-controlled drug delivery systems, the company evolved to specialize in advanced injection technologies. A key milestone was the development and commercialization of the CompuFlou00ae injection system.
Core Business Areas
- Computer-Controlled Injection Technology: Develops, patents, designs, and commercializes innovative computer-controlled injection technologies and handpieces across medical, dental, and cosmetic markets.
Leadership and Structure
Leonard Osser is the Interim Chief Executive Officer. The company has a board of directors and an executive team overseeing various departments including R&D, marketing, and sales.
Top Products and Market Share
Key Offerings
- Competitors: Teleflex (TFX).
- CompuFlou00ae Epidural System: A computer-controlled anesthesia delivery system used in epidural procedures. Market share data is difficult to pinpoint precisely, but Milestone is considered a notable player in this niche. Competitors include Teleflex (TFX).
- Competitors: Dentsply Sirona (XRAY).
- STAu00ae (Single Tooth Anesthesia) System: A computer-controlled local anesthesia delivery system for dental applications. Market share data is difficult to pinpoint precisely, but Milestone is considered a notable player in this niche. Competitors include Dentsply Sirona (XRAY).
- CathCheck: A device used for confirming proper placement of epidural catheters. Market share data is difficult to pinpoint precisely, but Milestone is considered a notable player in this niche. Competitors include Teleflex (TFX).
- Competitors: Teleflex (TFX).
Market Dynamics
Industry Overview
The market for computer-controlled injection systems is driven by the increasing demand for precise and painless drug delivery in medical, dental and cosmetic procedures. Growth is influenced by technological advancements and patient preferences.
Positioning
Milestone Scientific is positioned as an innovator in computer-controlled injection technology, focusing on niche markets where precision and patient comfort are paramount. It holds a competitive advantage through patented technology and a focused market approach.
Total Addressable Market (TAM)
The TAM for computer-controlled injection systems is estimated to be in the several billion USD range, encompassing medical, dental, and cosmetic applications. Milestone Scientific focuses on select segments within this TAM, aiming for a significant share through specialized products.
Upturn SWOT Analysis
Strengths
- Patented technology
- Specialized product focus
- Strong brand recognition in specific markets
Weaknesses
- Limited product diversification
- High operating expenses
- Dependence on regulatory approvals
Opportunities
- Expansion into new geographic markets
- Development of new applications for existing technology
- Strategic partnerships with medical device companies
Threats
- Competition from established medical device companies
- Technological obsolescence
- Changing regulatory landscape
Competitors and Market Share
Key Competitors
- Teleflex (TFX)
- Dentsply Sirona (XRAY)
- Becton, Dickinson and Company (BDX)
Competitive Landscape
Milestone Scientific faces intense competition from larger medical device companies with greater resources and broader product portfolios. Milestone's advantage lies in its specialized technology and focus on niche markets, but its limited scale presents a challenge.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends require specific financial data from company filings, which cannot be accessed in real time. Refer to company filings.
Future Projections: Future projections depend on analyst estimates, which require access to real-time financial reporting services, which cannot be provided here. Check recent financial news reports.
Recent Initiatives: Recent initiatives include expanding distribution networks, pursuing new product development, and securing regulatory approvals in key markets.
Summary
Milestone Scientific is a niche player with innovative computer-controlled injection technology. While their specialized focus is a strength, the company needs to increase market penetration and diversify its product offerings. Their key advantage is their patented technology, but competition from larger players with more resources is a continuous challenge. To sustain growth, Milestone needs to focus on strategic partnerships and geographic expansion.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings (Historical Data)
- Third-party market research reports (Limited Access)
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is based on estimates and may not be precise. Consult with a financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Milestone Scientific
Exchange NYSE MKT | Headquaters Roseland, NJ, United States | ||
IPO Launch date 1995-11-03 | CEO - | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 17 | |
Full time employees 17 | |||
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.